Herbs (Global Traditional) · European
Teucrium chamaedrys (Wall Germander)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Wall germander (Teucrium chamaedrys) is a Mediterranean herb containing neo-clerodane diterpenoids that traditionally supports digestive health and wound healing. The plant's bioactive compounds work through anti-inflammatory pathways, though hepatotoxic pyrrolizidine alkaloids limit its safety profile.
Teucrium chamaedrys, commonly known as Wall Germander, is a low-growing evergreen sub-shrub in the mint family native to Mediterranean regions including northern Africa, the Middle East, and southern Europe. Growing 6-18 inches tall with aromatic, scalloped leaves and pink-purple flowers, the aerial parts are typically harvested and used whole or as infusions in traditional preparations.
No human clinical trials, RCTs, or meta-analyses were identified for Teucrium chamaedrys in the available research. The compound has been studied only for its chemical composition and traditional uses, with no PubMed-indexed clinical studies available.
No clinically studied dosage ranges are available as human clinical studies are absent from the literature. Traditional preparations include infusions and decoctions of aerial parts, but specific doses have not been scientifically validated. Consult a healthcare provider before starting any new supplement.
Teucrium chamaedrys is not consumed as a food source and therefore lacks a conventional nutritional profile in terms of macronutrients (protein, carbohydrates, fat) or caloric value. Its relevance is entirely phytochemical. Key bioactive compounds include: • **Neo-clerodane diterpenoids** (teucrin A, teuchamaedryn A, teucrin B) — these are the primary compounds of concern, present at variable concentrations (~0.1–0.5% dry weight), and are responsible for documented hepatotoxicity via CYP3A4-mediated bioactivation into reactive epoxides. • **Flavonoids** — including luteolin, apigenin, cirsiliol, cirsimaritin, and diosmetin glycosides, collectively estimated at 1–3% of dry weight; these contribute antioxidant activity with moderate bioavailability typical of plant flavonoids. • **Phenolic acids** — caffeic acid, rosmarinic acid (~0.2–0.8% dry weight), chlorogenic acid; rosmarinic acid has documented anti-inflammatory and antioxidant properties with moderate oral bioavailability. • **Iridoid glycosides** — including harpagide and acetylharpagide, present in small quantities (~0.1–0.3%). • **Essential oil fraction** (~0.1–0.3% of aerial parts) — containing β-caryophyllene, germacrene D, α-humulene, and minor monoterpenes. • **Tannins** — condensed and hydrolyzable tannins contributing astringent properties, estimated at 3–7% dry weight. • **Saponins** — present in trace to low amounts. • **Mineral content** (from dried herb): potassium, calcium, magnesium, iron, and manganese in trace amounts typical of wild-harvested European herbs, though no standardized quantification exists for dietary relevance. • **Vitamins** — no significant vitamin content documented. **Critical bioavailability note:** The neo-clerodane diterpenoids, particularly teucrin A, are lipophilic and readily absorbed in the gastrointestinal tract, where hepatic first-pass metabolism by CYP3A4 converts them into hepatotoxic reactive metabolites. This has led to regulatory bans or restrictions on T. chamaedrys-containing products in France (1992) and advisories from multiple European health authorities. The beneficial flavonoids and phenolic acids have comparatively lower bioavailability and do not offset the hepatotoxic risk profile.
Wall germander's neo-clerodane diterpenoids, including teucrin A and teuchamaedryn A, modulate inflammatory cascades by inhibiting cyclooxygenase and lipoxygenase pathways. However, the herb contains hepatotoxic furan compounds that can cause oxidative stress and mitochondrial dysfunction in liver cells. The anti-inflammatory effects may contribute to its traditional use in digestive complaints and topical wound applications.
No controlled clinical trials have been conducted on wall germander's therapeutic effects. Traditional use evidence supports applications for gout, dyspepsia, and external wound healing, but these remain unvalidated by modern research standards. Case reports from the 1990s documented severe hepatotoxicity in users taking wall germander for weight loss, leading to regulatory restrictions. The lack of clinical data combined with documented liver toxicity makes risk-benefit assessment impossible.
Wall germander poses significant hepatotoxicity risks, with multiple case reports of acute liver injury, including fulminant hepatitis requiring liver transplantation. The herb is contraindicated in pregnancy, breastfeeding, and individuals with liver disease. Drug interactions may occur with hepatotoxic medications, alcohol, and drugs metabolized by liver enzymes. Many countries have banned or restricted wall germander due to its liver toxicity profile.
